Avidity Partners Management LP lessened its stake in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) by 96.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 64,501 shares of the company’s stock after selling 1,692,439 shares during the quarter. Avidity Partners Management […]
Survival Benefit Associated With Participation in Clinical Trials of Anticancer Drugs jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.
Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) had its price objective reduced by Mizuho from $4.00 to $3.00 in a research report report published on Tuesday morning, Benzinga reports. They currently have a neutral rating on the stock. A number of other equities research analysts have also weighed in on the company. The Goldman Sachs Group […]
Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) had its price target decreased by Mizuho from $4.00 to $3.00 in a report issued on Tuesday, Benzinga reports. Mizuho currently has a neutral rating on the stock. A number of other research firms have also recently weighed in on AMLX. HC Wainwright reaffirmed a buy rating and issued […]